QLARIS Trademark

Trademark Overview

On Friday, September 20, 2019, a trademark application was filed for QLARIS with the United States Patent and Trademark Office. The USPTO has given the QLARIS trademark a serial number of 88625126. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, January 23, 2023. This trademark is owned by Qlaris Bio, Inc.. The QLARIS trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Medical research; Research and development in the field of pharmaceuticals, therapeutics, drug formulation and delivery; Research and development in the pharmaceutical and biotechnology fields; Scientific research; Biochemical research and development; Clinical research in the field of pharmaceuticals, therapeutics, drug formulation and delivery; Pharmaceutical research and development; Product research and development; Scientific research and development
qlaris

General Information

Serial Number88625126
Word MarkQLARIS
Filing DateFriday, September 20, 2019
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, January 23, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 28, 2020

Trademark Statements

Goods and ServicesMedical research; Research and development in the field of pharmaceuticals, therapeutics, drug formulation and delivery; Research and development in the pharmaceutical and biotechnology fields; Scientific research; Biochemical research and development; Clinical research in the field of pharmaceuticals, therapeutics, drug formulation and delivery; Pharmaceutical research and development; Product research and development; Scientific research and development

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, September 26, 2019
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameQlaris Bio, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressWellesley, MA 02481
Party NameQlaris Bio, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressWaban, MA 02468

Trademark Events

Event DateEvent Description
Monday, January 23, 2023ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, January 23, 2023ABANDONMENT - NO USE STATEMENT FILED
Wednesday, June 22, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, June 20, 2022SOU EXTENSION 4 GRANTED
Monday, June 20, 2022SOU EXTENSION 4 FILED
Monday, June 20, 2022TEAS EXTENSION RECEIVED
Tuesday, January 11, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, January 10, 2022SOU EXTENSION 3 GRANTED
Thursday, December 23, 2021SOU EXTENSION 3 FILED
Monday, January 3, 2022CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, December 23, 2021TEAS EXTENSION RECEIVED
Wednesday, September 22, 2021APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, September 22, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, September 22, 2021TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Wednesday, September 22, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, September 22, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, September 22, 2021TEAS CHANGE OF OWNER ADDRESS RECEIVED
Saturday, June 12, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, June 10, 2021SOU EXTENSION 2 GRANTED
Thursday, June 10, 2021SOU EXTENSION 2 FILED
Thursday, June 10, 2021TEAS EXTENSION RECEIVED
Wednesday, December 23, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, December 21, 2020SOU EXTENSION 1 GRANTED
Monday, December 21, 2020SOU EXTENSION 1 FILED
Monday, December 21, 2020TEAS EXTENSION RECEIVED
Tuesday, June 23, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, April 28, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 28, 2020PUBLISHED FOR OPPOSITION
Wednesday, April 8, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, March 23, 2020ASSIGNED TO LIE
Monday, March 16, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, March 11, 2020EXAMINER'S AMENDMENT ENTERED
Wednesday, March 11, 2020NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, March 11, 2020EXAMINERS AMENDMENT E-MAILED
Wednesday, March 11, 2020EXAMINERS AMENDMENT -WRITTEN
Tuesday, March 10, 2020EXAMINER'S AMENDMENT ENTERED
Tuesday, March 10, 2020NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, March 10, 2020EXAMINERS AMENDMENT E-MAILED
Tuesday, March 10, 2020EXAMINERS AMENDMENT -WRITTEN
Monday, February 10, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, February 10, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, February 10, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, December 26, 2019NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, December 26, 2019NON-FINAL ACTION E-MAILED
Thursday, December 26, 2019NON-FINAL ACTION WRITTEN
Thursday, December 19, 2019ASSIGNED TO EXAMINER
Thursday, September 26, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, September 24, 2019NEW APPLICATION ENTERED

Related Keywords

qlaris research development delivery pharmaceutical scientific drug formulation field pharmaceuticals therapeutics